SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-20-000792
Filing Date
2020-03-12
Accepted
2020-03-12 07:16:24
Documents
93
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K zk2024098.htm 10-K 2109692
2 EXHIBIT 4.2 exhibit_4-2.htm EX-4.2 6246
3 EXHIBIT 10.26 exhibit_10-26.htm EX-10.26 281448
4 EXHIBIT 21.1 exhibit_21-1.htm EX-21.1 2971
5 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 7597
6 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 7576
7 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 4932
8 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 4995
15 image0.jpg GRAPHIC 21314
  Complete submission text file 0001178913-20-000792.txt   8919979

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT fomx-20191231.xml EX-101.INS 1955493
10 XBRL TAXONOMY EXTENSION SCHEMA fomx-20191231.xsd EX-101.SCH 66596
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fomx-20191231_cal.xml EX-101.CAL 86987
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fomx-20191231_def.xml EX-101.DEF 232254
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE fomx-20191231_lab.xml EX-101.LAB 521105
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fomx-20191231_pre.xml EX-101.PRE 395466
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36621 | Film No.: 20707144
SIC: 2833 Medicinal Chemicals & Botanical Products